# Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation (CH5)

**Page:** https://fundology.uk/fund/ch5 · ISIN LU1834986900

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 13/11/2026, CH5 (Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation, ISIN LU1834986900) closed at £143.36 on the London Stock Exchange. Its ongoing charge is 0.30% a year (about £30 on £10,000). Over the five years to 13/11/2026 its total return was +25.9%, or −1.7% after UK CPIH inflation.

## Summary

Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation is an exchange-traded fund (ETF) from Amundi, launched in 2019. It tracks the STOXX Europe 600 Health Care — large and medium-sized European companies. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.3% a year — about £30 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£143.36** (13/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | CH5 |
| ISIN | LU1834986900 |
| Also listed as | LHTC (Xetra, euros) |
| Category | Healthcare |
| Type | ETF |
| Provider | Amundi |
| Tracks | STOXX Europe 600 Health Care |
| Income | Accumulating |
| Ongoing charge | 0.30% a year (£30 per £10,000) |
| Fund size | £833m |
| Launched | 2019 |
| Domicile | Luxembourg |
| UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 22/03/2024 |

## Past returns (periods to 13/11/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +9.01% | +5.15% | income reinvested |
| 3 years | +25.27% | +13.17% | income reinvested |
| 5 years | +25.92% | -1.72% | income reinvested |

Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation in pounds (price, with income reinvested in the fund): 2022 +1.6%, 2023 +5.4%, 2024 −1.5%, 2025 +11.0%; 2026 to 13/11/2026 +9.2%. Returns of Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: −0.5%; to 30/09/2025: −3.2%; to 30/09/2024: +9.1%; to 30/09/2023: +14.0%; to 30/09/2022: +1.4%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2022 | +1.6% | -7.0% | Price |
| 2023 | +5.4% | +1.2% | Price |
| 2024 | -1.5% | -4.9% | Price |
| 2025 | +11.0% | +7.2% | Price |
| 2026 to 13/11/2026 | +9.2% | +5.7% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 18.16% | -12.62% |
| 3 years | 16.63% | -21.29% |
| 5 years | 15.96% | -21.29% |

## Largest fall

Volatility of Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation in pounds, annualised from weekly returns to 13/11/2026: 18.2% over 1 year, 16.6% over 3 years, 16.0% over 5 years. Largest fall in the price of Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation since November 2021, in pounds: −21.3% from 30/08/2024 to 11/04/2025. The lowest 12-month return of Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation in pounds (price, with income reinvested in the fund) since January 2021 was −16.8% (12 months to 08/08/2025); the highest was +26.4% (12 months to 08/04/2022). On 13/11/2026 the price of Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation was at its highest weekly close since November 2021, in pounds.

## Charges compared with similar funds

Ongoing charge of Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation 0.30% a year. Compared on 14/11/2026, 15 of the 28 other healthcare funds charge more, 2 the same and 11 less (share classes counted once).

## Funds tracking the same index

2 funds track STOXX Europe 600 Health Care, this one included and share classes counted once; their ongoing charges range from 0.30% to 0.46% a year (13/11/2026).

| Fund | Ongoing charge | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation (this fund) | 0.30% | +9.0% | +25.3% | +25.9% |
| iShares STOXX Europe 600 Health Care UCITS ETF (DE) | 0.46% | +9.2% | +25.2% | +25.8% |

Returns are as reported, in pounds, income reinvested unless marked "(price)".

## Charges & eligibility

- Ongoing charges figure (OCF): **0.30%** per year (as of 13/11/2026)
- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## What it holds

CH5 is a swap-based (synthetic) fund: it gets the return of the index it tracks through a swap. Its published holdings, as of 11/11/2026, are the substitute basket of securities the fund holds as collateral, not the companies in that index.

### Top holdings

Largest positions (as of 11/11/2026), as a percentage of the whole fund:

| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | ASML | [ASML](https://fundology.uk/stock/ASML) | 9.29% |
| 2 | Amazon | [AMZN](https://fundology.uk/stock/AMZN) | 7.67% |
| 3 | Wolters Kluwer | [WKL](https://fundology.uk/stock/WKL) | 7.63% |
| 4 | Munchener Ruckversicherungs-Gesellschaft | [MUV2](https://fundology.uk/stock/MUV2) | 7.16% |
| 5 | Seagate Technology | [STX](https://fundology.uk/stock/STX) | 4.65% |
| 6 | Sanofi | [SAN](https://fundology.uk/stock/EURONEXT:SAN) | 4.61% |
| 7 | Siemens | [SIE](https://fundology.uk/stock/SIE) | 3.90% |
| 8 | Edp | [EDP](https://fundology.uk/stock/EDP) | 3.76% |
| 9 | ING Groep | [INGA](https://fundology.uk/stock/INGA) | 3.76% |
| 10 | Novo Nordisk | [NOVO_B](https://fundology.uk/stock/NOVO_B) | 3.19% |

The 71 holdings on record (of 167 reported): https://fundology.uk/fund/ch5/holdings

## Questions people ask

**What is the ongoing charge of CH5?**

The ongoing charge of CH5 is 0.30% a year — about £30 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation 0.30% a year. Compared on 14/11/2026, 15 of the 28 other healthcare funds charge more, 2 the same and 11 less (share classes counted once).

**What does CH5 track?**

CH5 tracks the STOXX Europe 600 Health Care — large and medium-sized European companies.

**Is CH5 accumulating or distributing?**

CH5 is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

**What is the ISIN of CH5?**

The ISIN of CH5 is LU1834986900. An ISIN identifies one exact share class of a fund; CH5 is its ticker on the London Stock Exchange. The same share class is also listed as LHTC (Xetra, euros).

**What does CH5 hold?**

CH5 is a swap-based (synthetic) fund: it gets the return of the index it tracks through a swap. Its published holdings, as of 11/11/2026, are the substitute basket of securities the fund holds as collateral, not the companies in that index.

**What were CH5’s returns in each of the last five years?**

Calendar-year returns of CH5 in pounds (price, with income reinvested in the fund): 2022 +1.6%, 2023 +5.4%, 2024 −1.5%, 2025 +11.0%; 2026 to 13/11/2026 +9.2%. Past performance is not a guide to future returns.

**How has CH5 done after inflation?**

Over the five years to 13/11/2026 CH5’s total return was +25.9%, or −1.7% after UK CPIH inflation. Past performance is not a guide to future returns.

## Fund documents

- [Fund page at Amundi](https://www.amundietf.co.uk/en/professional/products/equity/amundi-stoxx-europe-600-healthcare-ucits-etf-acc/lu1834986900)
- Links checked 12/10/2026.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.
